CVRx Future Growth

Future criteria checks 2/6

CVRx is forecast to grow earnings and revenue by 31.2% and 29.3% per annum respectively. EPS is expected to grow by 34.4% per annum. Return on equity is forecast to be -99.5% in 3 years.

Key information

31.2%

Earnings growth rate

34.4%

EPS growth rate

Medical Equipment earnings growth16.5%
Revenue growth rate29.3%
Future return on equity-99.5%
Analyst coverage

Low

Last updated11 Apr 2024

Recent future growth updates

Recent updates

Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

Apr 10
Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Feb 29
The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Nov 11
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth

Aug 20
Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth

CVRx Pursues Revenue Growth But Operating Losses Worsen

Aug 05

CVRx: Barostim Story Looks Well Priced In, Overvalued At Just 5x Sales

Jun 21

We Think CVRx (NASDAQ:CVRX) Can Afford To Drive Business Growth

Apr 12
We Think CVRx (NASDAQ:CVRX) Can Afford To Drive Business Growth

Earnings Release: Here's Why Analysts Cut Their CVRx, Inc. (NASDAQ:CVRX) Price Target To US$20.33

Feb 18
Earnings Release: Here's Why Analysts Cut Their CVRx, Inc. (NASDAQ:CVRX) Price Target To US$20.33

CVRx: The Path To 7x Investment Returns

Jan 07

CVRx: High Risk And High Potential Reward

Jul 04

Earnings and Revenue Growth Forecasts

NasdaqGS:CVRX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026111-21-7-103
12/31/202577-34-20-235
12/31/202455-42-29-305
12/31/202339-41-40-39N/A
9/30/202335-43-43-42N/A
6/30/202331-43-46-45N/A
3/31/202326-43-43-42N/A
12/31/202222-41-43-43N/A
9/30/202219-41-40-39N/A
6/30/202216-38-38-37N/A
3/31/202214-44-35-33N/A
12/31/202113-43-29-28N/A
9/30/202111-36-26-25N/A
6/30/20219-33-21-21N/A
3/31/20217-19-17-17N/A
12/31/20206-14-16-16N/A
12/31/20196-15-13-13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CVRX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CVRX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CVRX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CVRX's revenue (29.3% per year) is forecast to grow faster than the US market (8% per year).

High Growth Revenue: CVRX's revenue (29.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CVRX is forecast to be unprofitable in 3 years.


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.